How effective is Remicade for Sarcoidosis? (a real world drug study)
Summary:
Overall ratings: 3/5 Long term ratings: 4/5
This is a phase IV clinical study of how effective Remicade (infliximab) is for Sarcoidosis and for what kind of people. The study is created by eHealthMe from 7 Remicade users and is updated continuously.
What is Remicade?
Remicade has active ingredients of infliximab. It is often used in crohn's disease. eHealthMe is studying from 224,011 Remicade users. Check the latest studies of Remicade.
What is Sarcoidosis?
Sarcoidosis (an inflammatory disease that affects multiple organs in the body, but mostly the lungs and lymph glands) is found to be associated with 552 drugs and 609 conditions by eHealthMe. Check the latest studies of Sarcoidosis.
7 people are studied for taking Remicade in Sarcoidosis
Overall effectiveness (number of people):
Long term (1+ years) effectiveness (number of people):
Remicade effectiveness for Sarcoidosis (number of people):
Overall:
- not at all: 1
- somewhat: 2
- moderate: 1
- high: 2
- very high: 1
Long Term:
- not at all: 0
- somewhat: 0
- moderate: 1
- high: 1
- very high: 1
Gender of people who take Remicade for Sarcoidosis *:
- female: 71.43 %
- male: 28.57 %
Age of people who take Remicade for Sarcoidosis *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 14.29 %
- 20-29: 14.29 %
- 30-39: 14.29 %
- 40-49: 42.86 %
- 50-59: 14.29 %
- 60+: 0.0 %
Who find Remicade more effective for Sarcoidosis?
Gender of people who take Remicade for Sarcoidosis *:
- female: 66.67 %
- male: 33.33 %
Age of people who take Remicade for Sarcoidosis *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 33.33 %
- 40-49: 33.33 %
- 50-59: 33.33 %
- 60+: 0.0 %
* Approximation only. Some reports may have incomplete information.
Do you take Remicade?
- You can start a phase IV clinical trial to monitor Remicade safety and effectiveness.How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Related publications that referenced our studies:
- ?UPANI? KRMEK DU, BRAJKOVI? I, BEKI? D, KRNI? A, JURKOVI? P, PAVLOVI? T, "CALCIFIED DEEP VEIN THROMBOSIS IN A PATIENT WITH RECURRENT DEEP VEIN THROMBOSIS AND SARCOIDOSIS", Acta Medica Croatica, 2014 Mar .
- Khedr YA, Khedr AH, "Sarcoidosis patient: an unexpected reaction to carbonic anhydrase enzyme inhibitor", BMJ case reports, 2013 Jul .
- Kang SM, Baek JY, Hwangbo B, Kim HY, Lee GK, Lee HS, "A case of capecitabine-induced sarcoidosis", Tuberculosis and respiratory diseases, 2012 Mar .
- ?UPANI? KRMEK DU, BRAJKOVI? I, BEKI? D, KRNI? A, JURKOVI? P, PAVLOVI? T, "CALCIFIED DEEP VEIN THROMBOSIS IN A PATIENT WITH RECURRENT DEEP VEIN THROMBOSIS AND SARCOIDOSIS", Acta Medica Croatica, 2014 Mar .
- Khedr YA, Khedr AH, "Sarcoidosis patient: an unexpected reaction to carbonic anhydrase enzyme inhibitor", BMJ case reports, 2013 Jul .
- Kang SM, Baek JY, Hwangbo B, Kim HY, Lee GK, Lee HS, "A case of capecitabine-induced sarcoidosis", Tuberculosis and respiratory diseases, 2012 Mar .
Related studies
Alternative drugs to, pros and cons of:
- Remicade (224,011 reports)
Treatments, associated drugs and conditions:
- Sarcoidosis (11,686 reports)
How the study uses the data?
The study is based on infliximab (the active ingredients of Remicade) and Remicade (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study neither.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Olumiant cause Pancytopenia? - a second ago
- Drug interactions of Enbrel and Etidronate Disodium - 3 seconds ago
- Drug interactions of Fish Oil and Sancuso - 3 seconds ago
- Could Stribild cause Bone Disorder? - 9 seconds ago
- Could Promethazine cause Metastases To Spine? - 30 seconds ago
- Astepro vs. Symbicort, side effect and effectiveness comparison - 31 seconds ago
- Drug interactions of Adcetris and Plavix - 37 seconds ago
- Could Miralax cause Clostridium Difficile Colitis? - 55 seconds ago
- Drug interactions of Econazole Nitrate and Centrum - 58 seconds ago
- Drug interactions of Cardura and Metolazone - a minute ago